Larson Financial Group’s Editas Medicine EDIT Stock Holding History

Larson Financial Group’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$936	Hold	289	–	–	﹤0.01%	3341
2026 Q1	$714	Buy	289 +45	+18%	+$95	﹤0.01%	3248
2025 Q4	$500	Hold	244	–	–	﹤0.01%	3120
2025 Q3	$847	Hold	244	–	–	﹤0.01%	2967
2025 Q2	$537	Hold	244	–	–	﹤0.01%	2838
2025 Q1	$283	Hold	244	–	–	﹤0.01%	2712
2024 Q4	$310	Hold	244	–	–	﹤0.01%	2325
2024 Q3	$832	Hold	244	–	–	﹤0.01%	2023
2024 Q2	$1.14K	Sell	244 -500	-67%	-$2.82K	﹤0.01%	1682
2024 Q1	$5.52K	Buy	744 +500	+205%	+$4.16K	﹤0.01%	1176
2023 Q4	$2.47K	Hold	244	–	–	﹤0.01%	1333
2023 Q3	$1.9K	Hold	244	–	–	﹤0.01%	1370
2023 Q2	$2.01K	Hold	244	–	–	﹤0.01%	1266
2023 Q1	$1.77K	Hold	244	–	–	﹤0.01%	1263
2022 Q4	$2.16K	Hold	244	–	–	﹤0.01%	1180
2022 Q3	$3K	Hold	244	–	–	﹤0.01%	1038
2022 Q2	$3K	Hold	244	–	–	﹤0.01%	950
2022 Q1	$5K	Hold	244	–	–	﹤0.01%	786
2021 Q4	$6K	Hold	244	–	–	﹤0.01%	773
2021 Q3	$10K	Hold	244	–	–	﹤0.01%	588
2021 Q2	$14K	Hold	244	–	–	﹤0.01%	494
2021 Q1	$10K	Buy	244 +100	+69%	+$5.7K	﹤0.01%	539
2020 Q4	$10K	Hold	144	–	–	﹤0.01%	490
2020 Q3	$4K	Buy	+144	New	+$4.69K	﹤0.01%	544
2020 Q1	–	Sell	-500	Closed	-$15K	–	561
2019 Q4	$15K	Buy	+500	New	+$12.5K	0.01%	258

Other funds holding EDIT

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Larson Financial Group's EDIT Position: Q2 2026 in Review

Larson Financial Group held its Editas Medicine (EDIT) position steady in Q2 2026 at 289 shares worth $936. The position accounts for ﹤0.01% of the portfolio, ranked #3341.

Larson Financial Group first reported a position in EDIT in Q4 2019 and has held it in 25 quarters since. The position peaked at $15K in Q4 2019. 215 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

Larson Financial Group held 289 shares of Editas Medicine worth $936 as of Q2 2026.
Larson Financial Group left its Editas Medicine share count unchanged in Q2 2026.
Editas Medicine made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #3341 holding.
Larson Financial Group first reported a position in Editas Medicine in Q4 2019 and has held it in 25 quarters since.
Larson Financial Group's Editas Medicine position peaked at $15K in Q4 2019.
215 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.